Skip to main content
OpenTrials
Completed

NCT Number: NCT01230515

Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol

The purpose of this study is to modify the opioid titration order sheet to meet the needs of the outpatient hospice population and to conduct a pilot trial to assess feasibility, utility, and derive preliminary efficacy data.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Vanderbilt-Ingam Cancer Center

Nashville, Tennessee, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient eligibility includes:
  • Alive Hospice outpatient
  • Diagnosis of carcinoma
  • Pain requiring fixed dose opioids
  • Age > 21 years
  • Not pregnant or lactating
  • Willing and able to sign informed consent
  • Able to speak/comprehend English

Caregiver eligibility will include:

  • Caregiver for an Alive Hospice patient
  • Willing and able to sign informed consent
  • Able to speak/comprehend English

Hospice Staff eligibility will include:

  • Currently on staff at Alive Hospice
  • Willing and able to sign informed consent
  • Able to read/speak English.

Referring Physician eligibility will include:

  • Having recently referred patients to Alive Hospice
  • Willing and able to sign informed consent and able to read/speak English.

Exclusion criteria

  • patients < 21 years of age
  • pregnant or lactating
  • patients, caregiver and or Hospice staff that does not speak/comprehend English

Treatment and study plan

Individual patient interview, focus group and structured survey

Other

interview, focus group and structured survey

Other

Primary outcomes

  1. Adequate pain control

    Time frame: Until death.

Sponsors and collaborators

Lead sponsor

Vanderbilt-Ingram Cancer Center

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2006
Primary completion
2007
Study completion
2008
First posted
Oct 29, 2010
Registry last updated
Sep 10, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.